Can GSK's widening late-stage research slate reshape the respiratory conversation?

Can GSK's widening late-stage research slate reshape the respiratory conversation? →

Highlights A wide slate of late-stage studies has pushed the research engine back to the centre of London's healthcare debate. Respiratory clearances in additional Asian markets extend the reach of an established franchise. Vaccines and spe…